Skip to main content
Year archive

Heidelberg Pharma AG — 2022 filings

All 62 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2022, sourced directly from the official regulator.

62 Filings
2022 Period
2022 filings (62)
Filing Released Lang
Heidelberg Pharma Signs Research and Exclusive Option Agreement with Binghamton University on Immunostimulatory Technology Platform
Regulatory Filings
2022-12-16 English
Heidelberg Pharma AG: Encouraging Clinical Data from Two Antibody Drug Conjugates Based on Heidelberg Pharmas ATAC Technology Presented at the ASH Annual Meeting 2022
Earnings Release Q4 2022
2022-12-14 English
Heidelberg Pharma and Partner Magenta to Present Initial Clinical Data on their Antibody Drug Conjugates at the ASH Annual Meeting 2022
Regulatory Filings
2022-11-10 English
Heidelberg Pharmas Partner Telix Reports Positive Data on the Pivotal ZIRCON Study
Regulatory Filings
2022-11-07 English
EQS-DD: Heidelberg Pharma AG english
Director's Dealing
2022-10-13 English
EQS-DD: Heidelberg Pharma AG english
Director's Dealing
2022-10-13 English
EQS-DD: Heidelberg Pharma AG english
Director's Dealing
2022-10-13 English
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2022
Earnings Release 9M 2022
2022-10-13 English
Quartalsfinanzbericht
Interim / Quarterly Report 9M 2022
2022-10-13 German
Q3 statement / Q3 financial report 2021/2022
Interim / Quarterly Report 9M 2022
2022-10-13 English
Heidelberg Pharma AG Announces Adjustment of Guidance
Earnings Release FY 2022
2022-10-04 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-09-14 English
Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate
Legal Proceedings Report
2022-09-09 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-09-07 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-09-07 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-09-07 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2022-09-06 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-09-06 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2022-09-05 English
Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure
Share Issue/Capital Change
2022-08-30 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2022-08-23 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2022-08-19 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2022-08-19 English
Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million
Capital/Financing Update
2022-08-12 English
Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate
M&A Activity
2022-07-13 English
Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022
Earnings Release H1 2022
2022-07-12 English
Halbjahresfinanzbericht
Interim / Quarterly Report H1 2022
2022-07-12 German
Half-yearly financial report 2021/2022
Interim / Quarterly Report H2 2022
2022-07-12 German
Heidelberg Pharma Reports Outcome of the Annual General Meeting 2022
AGM Information
2022-06-28 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-06-23 English
Report Publication Announcement 2022
Report Publication Announcement
2022-06-22 English
Hinweis auf Halbjahresfinanzbericht vom 01.12.2021 bis zum 31.05.2022
Report Publication Announcement
2022-06-22 German
Hinweis auf Halbjahresfinanzbericht vom 01.12.2021 bis zum 31.05.2022
Report Publication Announcement
2022-06-22 German
Heidelberg Pharma AG: Bekanntmachung der Einberufung zur Hauptversammlung am 22.06.2022 in Ladenburg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2022-05-17 German
Heidelberg Pharma AG and Partner Huadong Receive all Approvals for the Announced Transaction from the Authorities and Plan Capital Measure
M&A Activity
2022-05-09 English
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2022
Earnings Release Q1 2022
2022-04-28 English
Quartalsfinanzbericht
Interim / Quarterly Report Q1 2022
2022-04-28 German
Q1 statement / Q1 financial report 2021/2022
Interim / Quarterly Report Q1 2022
2022-04-28 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-04-12 German
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-04-12 German
Heidelberg Pharma to Present New Data on its Proprietary ATAC(R) Technology Platform at the AACR Annual Meeting 2022
Regulatory Filings
2022-04-07 English
Konzernabschluss zum Geschäftsjahr vom 01.12.2020 bis zum 30.11.2021
Annual Report (ESEF) FY 2021
2022-04-06 German
Annual financial report 2020/2021
Annual Report FY 2021
2022-03-29 English
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.12.2020 bis zum 30.11.2021
AGM Information
2022-03-28 German
Heidelberg Pharma announces financial figures for fiscal year 2021 and provides business update
Earnings Release FY 2021
2022-03-24 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2022-03-22 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2022-03-22 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-03-17 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-03-17 English
Heidelberg Pharma Receives Milestone Payment from Partner Magenta for Dosing the First Patient with MGTA-117
Earnings Release Q1 2022
2022-03-10 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-03-07 English
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment
Share Issue/Capital Change
2022-02-28 English
Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment
M&A Activity
2022-02-27 English
Ad-hoc-Meldung gemäß Art. 17 MAR in Verbindung mit § 4 Abs. 1 S. 1 Nr. 1a WpAV
M&A Activity
2022-02-27 German
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2022-02-22 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-02-22 German
Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini
Capital/Financing Update
2022-02-17 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-02-15 English
Heidelberg Pharma Announces First Patient Dosed with Antibody Targeted Amanitin Conjugate HDP-101 in Multiple Myeloma
Regulatory Filings
2022-02-15 English
Report Publication Announcement 2022
Report Publication Announcement
2022-02-14 English
Hinweis auf Jahresfinanzbericht vom 01.12.2020 bis zum 30.11.2021
Report Publication Announcement
2022-02-14 German
Hinweis auf Jahresfinanzbericht vom 01.12.2020 bis zum 30.11.2021
Report Publication Announcement
2022-02-14 German